Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremie Calais

Showing results (91-100 of 207) with videos related to

Pageof 21
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT in Adrenocortical Neoplasm, Oncocytic TypeKoichiro Kimura, Masha J Livhits, Israa A Laklouk, et al.
Methods (San Diego, Calif.)|February 23, 2025
A free method for patient-specific 3D-VR anatomical modeling for presurgical planning using DICOM images and open-source softwareZachary Ells, Vinicius Ludwig, Adam B Weiner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2023
Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent ReadersThomas A Hope, Matthias Benz, Fei Jiang, et al.
European Urology|April 23, 2026
Performance of [<sup>89</sup>Zr]girentuximab PET/CT in Predicting the Presence of Any Renal Malignancy: A Reanalysis of the ZIRCON TrialAboubacar Kaba, Pratik Kanabur, Jeremie Calais, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with <sup>177</sup>Lu-PSMA: A Retrospective, Single-Center StudyVishnu Murthy, Koichiro Kimura, Lela Theus, et al.
European Urology|October 20, 2024
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary CancersMartina Sollini, Jeremie Calais, Arturo Chiti, et al.
Radiology|March 31, 2021
Prostate-specific Membrane Antigen PET in Prostate CancerCourtney Lawhn-Heath, Ali Salavati, Spencer C Behr, et al.
European Urology Open Science|November 1, 2024
Clinical Responses to Prostate-specific Membrane Antigen Radioguided Salvage Lymphadenectomy for Prostate Cancer Recurrence: Results from a Prospective Exploratory TrialAdam B Weiner, Zachary Ells, Catherine Meyer, et al.
Clinical Nuclear Medicine|May 5, 2023
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature CellsMasatoshi Hotta, Christine E Mona, Joseph G Crompton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 21, 2024
SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PETThomas A Hope, Jeremie Calais, Ajit H Goenka, et al.
Pageof 21

Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
[<sup>68</sup>Ga]Ga-FAPI-46 PET/CT in Adrenocortical Neoplasm, Oncocytic TypeKoichiro Kimura, Masha J Livhits, Israa A Laklouk, et al.
Methods (San Diego, Calif.)|February 23, 2025
A free method for patient-specific 3D-VR anatomical modeling for presurgical planning using DICOM images and open-source softwareZachary Ells, Vinicius Ludwig, Adam B Weiner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2023
Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent ReadersThomas A Hope, Matthias Benz, Fei Jiang, et al.
European Urology|April 23, 2026
Performance of [<sup>89</sup>Zr]girentuximab PET/CT in Predicting the Presence of Any Renal Malignancy: A Reanalysis of the ZIRCON TrialAboubacar Kaba, Pratik Kanabur, Jeremie Calais, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with <sup>177</sup>Lu-PSMA: A Retrospective, Single-Center StudyVishnu Murthy, Koichiro Kimura, Lela Theus, et al.
European Urology|October 20, 2024
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary CancersMartina Sollini, Jeremie Calais, Arturo Chiti, et al.
Radiology|March 31, 2021
Prostate-specific Membrane Antigen PET in Prostate CancerCourtney Lawhn-Heath, Ali Salavati, Spencer C Behr, et al.
European Urology Open Science|November 1, 2024
Clinical Responses to Prostate-specific Membrane Antigen Radioguided Salvage Lymphadenectomy for Prostate Cancer Recurrence: Results from a Prospective Exploratory TrialAdam B Weiner, Zachary Ells, Catherine Meyer, et al.
Clinical Nuclear Medicine|May 5, 2023
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature CellsMasatoshi Hotta, Christine E Mona, Joseph G Crompton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 21, 2024
SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PETThomas A Hope, Jeremie Calais, Ajit H Goenka, et al.
Pageof 21